J., Zhang, Y
Mechanistically, it has been observed that GSTP1-1 binds, in its monomeric form, both c-Jun and JNK, thus forming an heterotrimeric complex that inhibits the phosphorylation of c-Jun by JNK
A separate NICE technology appraisal for tirzepatide in the management of overweight and obesity (under the brand name Zepbound in some markets) is a distinct process
The transient nature of side effects is supported by median duration data showing nausea episodes lasting 8 days, diarrhea 3 days, and vomiting 2 days
Medical Screening: Prior health assessments can help rule out contraindications like kidney, liver issues, or respiratory disorders
If you're currently taking a GLP-1 medication, don't stop it without talking to your healthcare provider